While my posts may appear negative today, I assure everyone
While my posts may appear negative today, I assure everyone that I am still positive regarding the future of this company. Dalton's flip-flopping around on what is holding back the financials and any kind of news at all is more than a little disconcerting. There either is a legal issue or there isn't --- how can there be an in between? Because a company has a legal issue, that does not mean there isn't an accounting issue. And, a regulator issue likely involves legal as well. So why did he say no legal issue and then come back latter and say it was a regulator and then come back later again and say he was waiting for signatures? Signatures on what? Maybe legal documents? I will just say this, if Dalton can't bring some semblance of clarity to what is happening to his company, then he isn't much of a manager.
Dalton was appointed to AGRiMED's Board of Directors for a reason, and I doubt it was to look good. Dalton was then promoted to Vice Chair of the Board. So AGRiMED must have felt he had value. In this position he has access to all the company is doing. So when Dalton tells Junebug the hold up is not AGRiMED, then it must be him. Who else is failing to get anything done?
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...
Continue Reading
Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....
Continue Reading
Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....
Continue Reading
Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...
Continue Reading
Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...
Continue Reading
